Literature DB >> 18820653

Adiponectin multimers and metabolic syndrome traits: relative adiponectin resistance in African Americans.

Cristina Lara-Castro1, Erin C Doud, Patrick C Tapia, Andres J Munoz, Jose R Fernandez, Gary R Hunter, Barbara A Gower, W Timothy Garvey.   

Abstract

African Americans (AAs) tend to have lower total adiponectin levels compared to European Americans (EA); however, it is not known whether race affects adiponectin multimer distribution and their relationships to metabolic traits. We measured total adiponectin, high molecular weight (HMW), low molecular weight (LMW) (i.e., hexamer), and trimer adiponectin in 132 normoglycemic premenopausal women (75 AAs, 57 EAs), together with measures of total and abdominal fat, plasma lipids, insulin sensitivity (S(i)), and genetic admixture estimates. We found that lower total adiponectin in AAs was explained by reduced LMW, and trimer forms because levels of HMW did not differ between races. In EAs, HMW was highly correlated with multiple metabolic syndrome traits. In contrast, the LMW and trimer forms were most highly correlated with metabolic traits in AAs, including abdominal adiposity, lipids, and S(i). At similar levels of visceral adiposity, AAs exhibited significantly lower LMW adiponectin than EAs. Similarly, at comparable levels of HMW and LMW adiponectin, AAs were more insulin resistant than their EA counterparts. In conclusion, (i) serum adiponectin is lower in AAs predominantly as a result of reduced concentrations of LMW and trimers multimeric forms; (ii) LMW and trimer, not HMW, are most broadly correlated with metabolic traits in AAs. Thus, HMW adiponectin may exert less bioactivity in explaining the metabolic syndrome trait cluster in populations of predominant African genetic background.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820653      PMCID: PMC2721223          DOI: 10.1038/oby.2008.411

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  42 in total

1.  Abdominal fat distribution and metabolic risk factors: effects of race.

Authors:  J C Lovejoy; J A de la Bretonne; M Klemperer; R Tulley
Journal:  Metabolism       Date:  1996-09       Impact factor: 8.694

2.  Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects.

Authors:  S Welch; S S Gebhart; R N Bergman; L S Phillips
Journal:  J Clin Endocrinol Metab       Date:  1990-12       Impact factor: 5.958

3.  Adiponectin as a biomarker of the metabolic syndrome.

Authors:  Miwa Ryo; Tadashi Nakamura; Shinji Kihara; Masahiro Kumada; Satomi Shibazaki; Mihoko Takahashi; Masaki Nagai; Yuji Matsuzawa; Tohru Funahashi
Journal:  Circ J       Date:  2004-11       Impact factor: 2.993

4.  Method of insulin administration has no effect on insulin sensitivity estimates from the insulin-modified minimal model protocol.

Authors:  M F Saad; G M Steil; M Riad-Gabriel; A Khan; A Sharma; R Boyadjian; S D Jinagouda; R N Bergman
Journal:  Diabetes       Date:  1997-12       Impact factor: 9.461

5.  Individual admixture estimates: disease associations and individual risk of diabetes and gallbladder disease among Mexican-Americans in Starr County, Texas.

Authors:  C L Hanis; R Chakraborty; R E Ferrell; W J Schull
Journal:  Am J Phys Anthropol       Date:  1986-08       Impact factor: 2.868

Review 6.  Using genetic admixture to study the biology of obesity traits and to map genes in admixed populations.

Authors:  José R Fernández; Mark D Shiver
Journal:  Nutr Rev       Date:  2004-07       Impact factor: 7.110

Review 7.  Adiponectin and metabolic syndrome.

Authors:  Yuji Matsuzawa; Tohru Funahashi; Shinji Kihara; Iichiro Shimomura
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-09       Impact factor: 8.311

8.  Relationship between serum adiponectin and leptin concentrations and body fat distribution.

Authors:  Keun-Gyu Park; Kyong-Soo Park; Mi-Jung Kim; Hye-Soon Kim; Young-Sung Suh; Jong-Doek Ahn; Kwan-Kyu Park; Young-Chae Chang; In-Kyu Lee
Journal:  Diabetes Res Clin Pract       Date:  2004-02       Impact factor: 5.602

9.  Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.

Authors:  Utpal B Pajvani; Meredith Hawkins; Terry P Combs; Michael W Rajala; Tom Doebber; Joel P Berger; John A Wagner; Margaret Wu; Annemie Knopps; Anny H Xiang; Kristina M Utzschneider; Steven E Kahn; Jerrold M Olefsky; Thomas A Buchanan; Philipp E Scherer
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

10.  Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes.

Authors:  Julia Tonelli; Weijie Li; Preeti Kishore; Utpal B Pajvani; Elize Kwon; Charles Weaver; Philipp E Scherer; Meredith Hawkins
Journal:  Diabetes       Date:  2004-06       Impact factor: 9.461

View more
  19 in total

Review 1.  The Interplay Between Sex, Ethnicity, and Adipose Tissue Characteristics.

Authors:  Kalypso Karastergiou
Journal:  Curr Obes Rep       Date:  2015-06

2.  Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals.

Authors:  Jonathan N Hofmann; Brenda M Birmann; Lauren R Teras; Ruth M Pfeiffer; Ye Wang; Demetrius Albanes; Dalsu Baris; Graham A Colditz; Anneclaire J De Roos; Graham G Giles; H Dean Hosgood; Qing Lan; Ola Landgren; Linda M Liao; Nathaniel Rothman; Stephanie J Weinstein; Michael N Pollak; Marian L Neuhouser; Mark P Purdue
Journal:  Cancer Res       Date:  2016-02-26       Impact factor: 12.701

3.  Circulating adiponectin is associated with obesity and serum lipids in West Africans.

Authors:  Katherine G Meilleur; Ayo Doumatey; Hanxia Huang; Bashira Charles; Guanjie Chen; Jie Zhou; Daniel Shriner; Adebowale Adeyemo; Charles Rotimi
Journal:  J Clin Endocrinol Metab       Date:  2010-04-09       Impact factor: 5.958

4.  Relationships of total adiponectin and molecular weight fractions of adiponectin with free testosterone in African men and premenopausal women.

Authors:  Jie Cui; XiangDong Wu; Jocelyn Andrel; Bonita Falkner
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-11-15       Impact factor: 3.738

5.  Paradoxical Hyperadiponectinemia is Associated With the Metabolically Healthy Obese (MHO) Phenotype in African Americans.

Authors:  Ayo P Doumatey; Amy R Bentley; Jie Zhou; Hanxia Huang; Adebowale Adeyemo; Charles N Rotimi
Journal:  J Endocrinol Metab       Date:  2012-04-01

6.  Associations among calcium intake, resting energy expenditure, and body fat in a multiethnic sample of children.

Authors:  Lynae J Hanks; Krista Casazza; Amanda L Willig; Michelle I Cardel; T Mark Beasley; Jose R Fernandez
Journal:  J Pediatr       Date:  2010-04-18       Impact factor: 4.406

7.  Serum adiponectin in relation to body mass index and other correlates in black and white women.

Authors:  Sarah S Cohen; Marilie D Gammon; Lisa B Signorello; Kari E North; Ethan M Lange; Jay H Fowke; Margaret K Hargreaves; Qiuyin Cai; Wei Zheng; William J Blot; Charles E Matthews
Journal:  Ann Epidemiol       Date:  2010-12-15       Impact factor: 3.797

8.  Intramyocellular lipid and insulin resistance: differential relationships in European and African Americans.

Authors:  Katherine H Ingram; Cristina Lara-Castro; Barbara A Gower; Robert Makowsky; David B Allison; Bradley R Newcomer; A Julian Munoz; T Mark Beasley; Jeannine C Lawrence; Robert Lopez-Ben; Dana Y Rigsby; W Timothy Garvey
Journal:  Obesity (Silver Spring)       Date:  2011-03-24       Impact factor: 5.002

9.  Adiposity and genetic admixture, but not race/ethnicity, influence bone mineral content in peripubertal children.

Authors:  Krista Casazza; Olivia Thomas; Akilah Dulin-Keita; Jose R Fernandez
Journal:  J Bone Miner Metab       Date:  2010-01-20       Impact factor: 2.626

10.  Insulin sensitivity in African-American and white women: association with inflammation.

Authors:  Tanya C Hyatt; Radhika P Phadke; Gary R Hunter; Nikki C Bush; A Julian Muñoz; Barbara A Gower
Journal:  Obesity (Silver Spring)       Date:  2008-11-27       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.